• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后斑块体积及围手术期心肌坏死的发生情况和位置:延迟强化磁共振成像、心肌梗死溶栓治疗心肌灌注分级分析及血管内超声的见解

Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.

作者信息

Porto Italo, Selvanayagam Joseph B, Van Gaal William J, Prati Francesco, Cheng Adrian, Channon Keith, Neubauer Stefan, Banning Adrian P

机构信息

Department of Cardiology, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

出版信息

Circulation. 2006 Aug 15;114(7):662-9. doi: 10.1161/CIRCULATIONAHA.105.593210. Epub 2006 Aug 7.

DOI:10.1161/CIRCULATIONAHA.105.593210
PMID:16894040
Abstract

BACKGROUND

Myocardial necrosis can occur during percutaneous coronary intervention (PCI) despite optimal adjunctive pharmacology and careful technique. We investigated the mechanisms of procedural infarction using angiographic analysis, intravascular ultrasound, and delayed-enhancement magnetic resonance imaging.

METHODS AND RESULTS

Fifty-two patients (64 vessels) who underwent complex PCI were studied. All patients were preloaded with clopidogrel and received glycoprotein IIb/IIIa inhibitors. "Adjacent" myonecrosis was defined as the presence of an area of new gadolinium hyperenhancement close to the stent. "Distal" myonecrosis was defined as situated at least 10 mm downstream from the stent. Fifteen vessels (23%) had evidence of new hyperenhancement after PCI. Of these, 8 (12%) had the distal type, and 7 (11%) had the adjacent type. Intravascular ultrasound showed a significantly greater reduction in plaque volume (91.6+/-51.5 versus 8+/-14 versus 20+/-35 mm3; P < 0.001) in the group with distal hyperenhancement compared with patients without new hyperenhancement or adjacent hyperenhancement. In the entire sample, a significant correlation was seen between changes in plaque volume (rho = 0.58, P < 0.001) after PCI and the mass of new necrosis measured by magnetic resonance imaging. Thrombolysis in Myocardial Infarction perfusion grade assessment of a closed microvasculature after PCI carried an odds ratio of 8.0 (95% confidence interval, 1.4 to 46.1; P = 0.02) for the occurrence of hyperenhancement, whereas side-branch occlusion was associated with an odds ratio of 16.2 (95% confidence interval, 2.6 to 102.5; P = 0.03). However, a closed microvasculature was associated with distal hyperenhancement (P = 0.02), and side-branch occlusion was associated with adjacent hyperenhancement (P < 0.001).

CONCLUSIONS

These data suggest that distal embolization of plaque material occurs in contemporary PCI of native coronary arteries. Efforts to minimize procedural necrosis may require careful review of side branch anatomy and/or use of distal protection during extensive coronary stenting.

摘要

背景

尽管采用了最佳的辅助药物治疗并谨慎操作技术,但经皮冠状动脉介入治疗(PCI)过程中仍可能发生心肌坏死。我们使用血管造影分析、血管内超声和延迟强化磁共振成像研究了手术梗死的机制。

方法和结果

对52例(64支血管)接受复杂PCI的患者进行了研究。所有患者均预先服用氯吡格雷并接受糖蛋白IIb/IIIa抑制剂治疗。“相邻”心肌坏死定义为靠近支架处存在新的钆增强区域。“远端”心肌坏死定义为位于支架下游至少10毫米处。15支血管(23%)在PCI后有新的增强证据。其中,8支(12%)为远端型,7支(11%)为相邻型。血管内超声显示,与无新增强或相邻增强的患者相比,远端增强组的斑块体积显著减小(91.6±51.5对8±14对20±35立方毫米;P<0.001)。在整个样本中,PCI后斑块体积变化(rho=0.58,P<0.001)与磁共振成像测量的新坏死质量之间存在显著相关性。PCI后闭塞微血管的心肌梗死溶栓灌注分级评估显示,发生增强的比值比为8.0(95%置信区间,1.4至46.1;P=0.02),而侧支闭塞的比值比为16.2(95%置信区间,2.6至102.5;P=0.03)。然而,闭塞微血管与远端增强相关(P=0.02),侧支闭塞与相邻增强相关(P<0.001)。

结论

这些数据表明,在当代天然冠状动脉PCI中会发生斑块物质的远端栓塞。尽量减少手术坏死的努力可能需要仔细评估侧支解剖结构和/或在广泛冠状动脉支架置入过程中使用远端保护装置。

相似文献

1
Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.经皮冠状动脉介入治疗后斑块体积及围手术期心肌坏死的发生情况和位置:延迟强化磁共振成像、心肌梗死溶栓治疗心肌灌注分级分析及血管内超声的见解
Circulation. 2006 Aug 15;114(7):662-9. doi: 10.1161/CIRCULATIONAHA.105.593210. Epub 2006 Aug 7.
2
Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study.经皮冠状动脉介入治疗后远端栓塞对心肌灌注储备的影响:一项定量磁共振灌注研究
Circulation. 2007 Sep 25;116(13):1458-64. doi: 10.1161/CIRCULATIONAHA.106.671909. Epub 2007 Sep 4.
3
Below radar: contributions of cardiac magnetic resonance to the understanding of myonecrosis after percutaneous coronary intervention.未受关注的领域:心脏磁共振成像对经皮冠状动脉介入治疗后心肌坏死认识的贡献
Circulation. 2006 Aug 15;114(7):620-2. doi: 10.1161/CIRCULATIONAHA.106.644732.
4
Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.经皮冠状动脉介入治疗后肌钙蛋白升高直接反映不可逆心肌损伤的程度:来自心血管磁共振成像的见解
Circulation. 2005 Mar 1;111(8):1027-32. doi: 10.1161/01.CIR.0000156328.28485.AD. Epub 2005 Feb 21.
5
Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.支架时代经皮冠状动脉介入治疗后非Q波心肌梗死的发生:心肌坏死三项标志物的系统监测
J Interv Cardiol. 2005 Aug;18(4):243-8. doi: 10.1111/j.1540-8183.2005.00042.x.
6
Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.择期经皮冠状动脉介入治疗后不久出现的冠状动脉内ST段移位可准确预测围手术期心肌损伤。
Circulation. 2006 Oct 31;114(18):1948-54. doi: 10.1161/CIRCULATIONAHA.106.620476. Epub 2006 Oct 23.
7
Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.心肌梗死溶栓治疗心肌灌注分级与ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后梗死灶结构的心血管磁共振测量指标的相关性
Am Heart J. 2009 Jul;158(1):84-91. doi: 10.1016/j.ahj.2009.04.012.
8
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.血小板糖蛋白IIb/IIIa抑制剂在隐静脉移植血管经皮冠状动脉介入治疗中的应用及临床结局
Am J Cardiol. 2006 Oct 1;98(7):906-10. doi: 10.1016/j.amjcard.2006.04.037. Epub 2006 Aug 17.
9
Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction.在接受替罗非班治疗的ST段抬高型心肌梗死患者经皮冠状动脉介入治疗前,进行极早期心脏磁共振成像以定量评估心肌组织灌注。
Am Heart J. 2005 Mar;149(3):564. doi: 10.1016/j.ahj.2004.06.023.
10
Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.替罗非班辅助治疗对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者的临床益处。
Coron Artery Dis. 2008 Jun;19(4):271-7. doi: 10.1097/MCA.0b013e3282f487e0.

引用本文的文献

1
Current Challenges in Coronary Bifurcation Interventions.冠状动脉分叉病变介入治疗的当前挑战。
Medicina (Kaunas). 2024 Sep 3;60(9):1439. doi: 10.3390/medicina60091439.
2
Periprocedural Myocardial Infarction following Elective Percutaneous Coronary Interventions.择期经皮冠状动脉介入治疗后的围手术期心肌梗死
Rev Cardiovasc Med. 2022 Sep 13;23(9):309. doi: 10.31083/j.rcm2309309. eCollection 2022 Sep.
3
Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention.
瑞诺嗪、缺血预处理与择期经皮冠状动脉介入治疗患者的心肌保护作用之间的相关性。
Medicina (Kaunas). 2024 Jan 16;60(1):166. doi: 10.3390/medicina60010166.
4
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction.急性心肌梗死患者的冠状动脉微血管阻塞和功能障碍。
Nat Rev Cardiol. 2024 May;21(5):283-298. doi: 10.1038/s41569-023-00953-4. Epub 2023 Nov 24.
5
Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction.ST段抬高型心肌梗死延迟药物介入治疗的可行性与疗效
World J Cardiol. 2023 Jan 26;15(1):23-32. doi: 10.4330/wjc.v15.i1.23.
6
Impact of coronary plaque characteristics on periprocedural myocardial injury in elective percutaneous coronary intervention.择期经皮冠状动脉介入治疗中冠状动脉斑块特征对围术期心肌损伤的影响。
Eur Radiol. 2023 May;33(5):3020-3028. doi: 10.1007/s00330-022-09288-z. Epub 2022 Nov 28.
7
The Effect of Alcoholic Extract of on Biochemical and Histological Parameters in Rats.[提取物名称]乙醇提取物对大鼠生化及组织学参数的影响 (原文中“of”后面缺少具体提取物名称)
J Toxicol. 2022 Mar 24;2022:6945745. doi: 10.1155/2022/6945745. eCollection 2022.
8
A fresh look at coronary microembolization.冠状动脉微栓塞的新视角。
Nat Rev Cardiol. 2022 Apr;19(4):265-280. doi: 10.1038/s41569-021-00632-2. Epub 2021 Nov 16.
9
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).经皮冠状动脉介入治疗相关的围术期心肌损伤和梗死的预后相关因素:ESC 心脏细胞生物学工作组和欧洲经皮心血管介入协会(EAPCI)的共识文件。
Eur Heart J. 2021 Jul 15;42(27):2630-2642. doi: 10.1093/eurheartj/ehab271.
10
Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.围手术期心肌损伤对接受经皮冠状动脉介入治疗的慢性完全闭塞患者长期临床结局的影响:一项系统评价和荟萃分析。
Coron Artery Dis. 2020 May;31(3):208-214. doi: 10.1097/MCA.0000000000000813.